Industries - Digital Therapeutics Market Analysis by Application (Nutrition, Diabetes, CNS Disorder, CVD, Respiratory Disorder, MSD, GI, Drug addiction), by Product Type (Software, Hardware), by End User (B2B, B2C), and by Region – Forecast to 2026

Ablation Technology Market Analysis

Digital Therapeutics Market Analysis by Application (Nutrition, Diabetes, CNS Disorder, CVD, Respiratory Disorder, MSD, GI, Drug addiction), by Product Type (Software, Hardware), by End User (B2B, B2C), and by Region – Forecast to 2026
May 2021

SKU: N/A Category:
Clear
  • Description
  • Additional information
  • Enquire about

Description

Digital Therapeutics Market Analysis by Application (Nutrition, Diabetes, CNS Disorder, CVD, Respiratory Disorder, MSD, GI, Drug addiction), by Product Type (Software, Hardware), by End User (B2B, B2C), and by Region - Forecast to 2026

Published: May 2021 | Historical Data: 2017-2020 | Base Year: 2020
SKU: ICI-HC-1126 | Number of Pages: 157 | Category: Healthcare IT

The global digital therapeutics market was valued at USD 3,193.2 million in 2020 and is expected to witness a CAGR of 22.1% during the forecast period. Technological advancements in products, government initiatives to provide improved healthcare services, adoption of smart technology by consumers, and growing need to minimize healthcare costs are major factors that propel the global market growth. However, patient data privacy issues, lack of awareness, and unavailability of explicit training programs for digital therapeutics in emerging economies are expected to hinder the growth.

Digital Therapeutics Market Analysis

By Application

Based on application, the market is categorized into nutrition, diabetes, central nervous system disorder, cardiovascular disease, respiratory disorder, musculoskeletal disorder, gastrointestinal disorder, drug addiction, and others. In 2020, the diabetes segment accounted for the highest revenue share. This is due to the growing prevalence of diabetes coupled with rising need for cost-effective personalized diabetic treatment worldwide. The nutrition segment is estimated to grow at a significant CAGR during the forecast period owing to the large number of obese population that leads to the pervasiveness of chronic diseases.

By Product Type

Based on product type, the market is segmented into hardware and software. In 2020, the hardware segment accounted for a significant revenue share owing to its larger penetration and adoption among B2B and B2C users. The software segment is projected to grow at a lucrative CAGR during the forecast period owing to increasing R&D in medical software sector.

By End User

On the basis of end user, the market is categorized into business-to-business (B2B) and business-to-consumers segment (B2C). The B2B segment is sub-segmented into employers, hospitals, pharmaceutical firms, and others. This segment accounted for the largest revenue share in 2020 owing to the increasing application of digital therapeutics to provide cost-effective and rapid care to patients. The B2C segment is further subdivided into patients and caregivers.

Regional Insights

North America was the highest revenue-grossing segment of the global market in 2020 and is projected to maintain its dominance during the forecast period. This is due to the high adoption of patient-centric medical solutions and rapidly rising demand to reduce healthcare facility’s maintenance expense in this region. The Asia Pacific market is estimated to grow at the fastest growth rate during the forecast period owing to the increasing adoption of digital technology in healthcare sector, significant funding by venture capitalists & government bodies to develop medical infrastructure, and rising prevalence of chronic diseases including diabetes and obesity.

North America Digital Therapeutics Market Size (2017-2026), USD Million

North America Digital Therapeutics Market

Competitor Insights

Some of the major companies in the digital therapeutics market are Noom, Inc., Fitbit, Inc., TrialCard Incorporated, ResMed, Canary Health, Inc., Medtronic PLC, WellDoc, Inc., Omada Health, Inc., Kaia Health, and Livongo Health, Inc. Strategic partnerships, mergers & acquisitions, investment in R&D, and geographic expansion are some of the major strategies adopted by the leading players operating in the industry.

Key Market Developments:

  • January 2020: Noom and EVERSANA announced a strategic collaboration to improve patient outcomes and increase medication adherence for patients with chronic conditions and rare diseases.
  • December 2019: Medtronic PLC acquired Klue, INc., a digital health technology company offering behavior change and real-time digital therapeutic solutions.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2017 to 2026. The digital therapeutics market report is categorized into the following segments and subsegments:

Digital Therapeutics Market, By Application (Revenue, 2017-2026, USD Million)

  • Nutrition
  • Diabetes
  • Cardiovascular Disorder
  • Central Nervous System Disorder
  • Musculoskeletal Disorder
  • Gastrointestinal Disorder
  • Respiratory Disease
  • Drug Addiction
  • Others

Digital Therapeutics Market, By Product Type (Revenue, 2017-2026, USD Million)

  • Hardware
  • Software

Digital Therapeutics Market, By End User (Revenue, 2017-2026, USD Million)

  • Business-to-Business
    • Hospitals
    • Payers
    • Pharmaceutical Firms
    • Others
  • Business-to-Consumers
    • Patients
    • Caregivers

Digital Therapeutics Market, By Region (Revenue, 2017-2026, USD Million)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Digital Therapeutics Market Report:

Key Parameters Details
Data Availability 2017-2026
Historical Years 2017-2020
Base Year Considered 2020
Forecast Period 2020-2026
Company Profiles 10
Companies Considered (Across Value Chain) >60
Value Units Value in USD and CAGR in %
Market Segments Application, Product Type, and End User
Regional Coverage North America (U.S. and Canada), Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe), Asia Pacific (China, Japan, Australia, India, South Korea, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), and the Middle East & Africa (South Africa, Saudi Arabia, Rest of MEA)
Key Market Players Noom, Inc., Fitbit, Inc., TrialCard Incorporated, ResMed, Canary Health, Inc., Medtronic PLC, WellDoc, Inc., Omada Health, Inc., Kaia Health, and Livongo Health, Inc.
Custom Analysis Customization up to 60 analyst hours

Digital Therapeutics Market, By Application (Revenue, 2017-2026, USD Million)

  • Nutrition
  • Diabetes
  • Cardiovascular Disorder
  • Central Nervous System Disorder
  • Musculoskeletal Disorder
  • Gastrointestinal Disorder
  • Respiratory Disease
  • Drug Addiction
  • Others

Digital Therapeutics Market, By Product Type (Revenue, 2017-2026, USD Million)

  • Hardware
  • Software

Digital Therapeutics Market, By End User (Revenue, 2017-2026, USD Million)

  • Business-to-Business
    • Hospitals
    • Payers
    • Pharmaceutical Firms
    • Others
  • Business-to-Consumers
    • Patients
    • Caregivers

Digital Therapeutics Market, By Region (Revenue, 2017-2026, USD Million)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA
1. Research Methodology
  1.1. Research Objective
  1.2. Study Scope: Market Segments
  1.3. Study Timeframe, Limitations & Currency
  1.4. Domain-Assisted Cognition (DAC) Framework
    1.4.1. Three-stage Research Methodology
      1.4.1.1. Understand Ecosystem
        1.4.1.1.1. Secondary Research
        1.4.1.1.2. Primary Research
        1.4.1.1.3. Internal Repository
      1.4.1.2. Synthesize Information
        1.4.1.2.1. Data Analysis
        1.4.1.2.2. Data Triangulation
      1.4.1.3. Predict/Project Growth
        1.4.1.3.1. Market Size Estimation
          1.4.1.3.1.1. Bottom-up Approach
          1.4.1.3.1.2. Top-down Approach
        1.4.1.3.2. Data Validation
    1.4.2. Two-stage Quality Check Mechanism
      1.4.2.1. Inspection & Reporting
      1.4.2.2. Quality Audit
2. Market Summary
  2.1. Market Definition & Market Landscape
  2.2. Market Segment Snapshot
  2.3. Geographic Market Snapshot
3. Market Dynamics
  3.1. Market Driver Analysis
    3.1.1. Technological advancements in digital medical solutions
    3.1.2. Government & private initiatives for improved healthcare systems
    3.1.3. Rising consumer awareness for application of digital technology in healthcare
  3.2. Market Restraint Analysis
    3.2.1. Patient data privacy issue
    3.2.2. Unavailability of explicit training programs for digital therapeutics Awareness
  3.3. Market Opportunities
    3.3.1. Rising demand for preventive healthcare systems in emerging economies
    3.3.2. Unmapped therapeutics application in treatment and diagnosis of chronic diseases
4. Industry Outlook
  4.1. Key Market Trends
  4.2. Value Chain Analysis
  4.3. Porter’s 5 Forces Analysis
  4.4. Pricing Analysis (2017-2020)
  4.5. Product Benchmarking
5. Covid-19 Impact and Deviation Analysis
  5.1. Covid-19 Prevalence Analysis
  5.2. Key Market Trends
  5.3. Market Size Deviation Analysis (2020-2026)
6. Digital Therapeutics Market Size and Forecast, By Application (2017-2026), USD Million
  6.1. Nutrition
  6.2. Diabetes
  6.3. Cardiovascular Disorder
  6.4. Central Nervous System Disorder
  6.5. Musculoskeletal Disorder
  6.6. Gastrointestinal Disorder
  6.7. Respiratory Disease
  6.8. Drug Addiction
  6.9. Others
7. Digital Therapeutics Market Size and Forecast, By Product Type (2017-2026), USD Million
  7.1. Hardware
  7.2. Software
8. Digital Therapeutics Market Size and Forecast, By End User (2017-2026), USD Million
  8.1. Business-to-Business
    8.1.1. Hospitals
    8.1.2. Payers
    8.1.3. Pharmaceutical Firms
    8.1.4. Others
  8.2. Business-to-Consumers
    8.2.1. Patients
    8.2.2. Caregivers
9. Digital Therapeutics Market, Regional Analysis (2017-2026), USD Million
  9.1. North America
    9.1.1. Introduction
      9.1.1.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.1.1.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.1.1.3. Market Size & Forecast, by End User (2017-2026), USD Million
      9.1.1.4. Market Size & Forecast, by Country (2017-2026), USD Million
    9.1.2. U.S.
      9.1.2.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.1.2.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.1.2.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.1.3. Canada
      9.1.3.1. Market Size & Forecast, by Product (2017-2026), USD Million
      9.1.3.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.1.3.3. Market Size & Forecast, by End User (2017-2026), USD Million
  9.2. Europe
    9.2.1. Introduction
      9.2.1.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.2.1.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.2.1.3. Market Size & Forecast, by End User (2017-2026), USD Million
      9.2.1.4. Market Size & Forecast, by Country (2017-2026), USD Million
    9.2.2. Germany
      9.2.2.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.2.2.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.2.2.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.2.3. UK
      9.2.3.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.2.3.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.2.3.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.2.4. France
      9.2.4.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.2.4.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.2.4.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.2.5. Spain
      9.2.5.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.2.5.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.2.5.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.2.6. Italy
      9.2.6.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.2.6.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.2.6.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.2.7. Russia
      9.2.7.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.2.7.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.2.7.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.2.8. Rest of Europe
      9.2.8.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.2.8.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.2.8.3. Market Size & Forecast, by End User (2017-2026), USD Million
  9.3. Asia Pacific (APAC)
    9.3.1. Introduction
      9.3.1.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.3.1.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.3.1.3. Market Size & Forecast, by End User (2017-2026), USD Million
      9.3.1.4. Market Size & Forecast, by Country (2017-2026), USD Million
    9.3.2. China
      9.3.2.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.3.2.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.3.2.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.3.3. Japan
      9.3.3.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.3.3.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.3.3.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.3.4. India
      9.3.4.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.3.4.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.3.4.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.3.5. Australia
      9.3.5.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.3.5.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.3.5.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.3.6. South Korea
      9.3.6.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.3.6.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.3.6.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.3.7. Rest of Asia Pacific
      9.3.7.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.3.7.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.3.7.3. Market Size & Forecast, by End User (2017-2026), USD Million
  9.4. Latin America (LATAM)
    9.4.1. Introduction
      9.4.1.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.4.1.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.4.1.3. Market Size & Forecast, by End User (2017-2026), USD Million
      9.4.1.4. Market Size & Forecast, by Country (2017-2026), USD Million
    9.4.2. Brazil
      9.4.2.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.4.2.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.4.2.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.4.3. Mexico
      9.4.3.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.4.3.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.4.3.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.4.4. Argentina
      9.4.4.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.4.4.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.4.4.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.4.5. Rest of LATAM
      9.4.5.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.4.5.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.4.5.3. Market Size & Forecast, by End User (2017-2026), USD Million
  9.5. Middle East & Africa (MEA)
    9.5.1. Introduction
      9.5.1.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.5.1.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.5.1.3. Market Size & Forecast, by End User (2017-2026), USD Million
      9.5.1.4. Market Size & Forecast, by Country (2017-2026), USD Million
    9.5.2. South Africa
      9.5.2.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.5.2.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.5.2.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.5.3. Saudi Arabia
      9.5.3.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.5.3.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.5.3.3. Market Size & Forecast, by End User (2017-2026), USD Million
    9.5.4. Rest of MEA
      9.5.4.1. Market Size & Forecast, by Application (2017-2026), USD Million
      9.5.4.2. Market Size & Forecast, by Product Type (2017-2026), USD Million
      9.5.4.3. Market Size & Forecast, by End User (2017-2026), USD Million
10. Competitor Analysis
  10.1. Market Player Comparison
  10.2. Product-wise Player Mapping
  10.3. Region-wise Player Mapping
  10.4. Market Share Analysis
  10.5. Market Position Analysis
  10.6. Recent Development Analysis
11. Company Profiles
  11.1. Noom, Inc.
    11.1.1. Company Overview
    11.1.2. Company Financials
    11.1.3. Product Portfolio
    11.1.4. Recent Developments
  11.2. Fitbit, Inc.
    11.2.1. Company Overview
    11.2.2. Company Financials
    11.2.3. Product Portfolio
    11.2.4. Recent Developments
  11.3. TrialCard Incorporated
    11.3.1. Company Overview
    11.3.2. Company Financials
    11.3.3. Product Portfolio
    11.3.4. Recent Developments
  11.4. ResMed
    11.4.1. Company Overview
    11.4.2. Company Financials
    11.4.3. Product Portfolio
    11.4.4. Recent Developments
  11.5. Medtronic PLC
    11.5.1. Company Overview
    11.5.2. Company Financials
    11.5.3. Product Portfolio
    11.5.4. Recent Developments
  11.6. WellDoc, Inc.
    11.6.1. Company Overview
    11.6.2. Company Financials
    11.6.3. Product Portfolio
    11.6.4. Recent Developments
  11.7. Omada Health, Inc.
    11.7.1. Company Overview
    11.7.2. Company Financials
    11.7.3. Product Portfolio
    11.7.4. Recent Developments
  11.8. WellDoc, Inc.
    11.8.1. Company Overview
    11.8.2. Company Financials
    11.8.3. Product Portfolio
    11.8.4. Recent Developments
  11.9. Kaia Health
    11.9.1. Company Overview
    11.9.2. Company Financials
    11.9.3. Product Portfolio
    11.9.4. Recent Developments
  11.10. Livongo Health, Inc.
    11.10.1. Company Overview
    11.10.2. Company Financials
    11.10.3. Product Portfolio
    11.10.4. Recent Developments
(Note: Financials are captured for public listed companies)

Key questions addressed by the research report-

  1. What are the current market trends and future market forecast from 2020 to 2026 for digital therapeutics market?
  2. What are the market dynamics and probable opportunities for market players during the forecast period?
  3. Initiatives undertaken my market players to address the COVID-19 impact to sustain in the competitive market.
  4. Which geographies have immense opportunities in different segments of the digital therapeutics market?
  5. What are the recent strategies adopted by market players such as product launch, partnership, agreement, collaboration, merger & acquisition, and geographical expansion?


    Have any question? Check your free sample before purchase or connect with our expert.

    Additional information

    Licensing Types

    , , ,

    Enquire about Digital Therapeutics Market Analysis by Application (Nutrition, Diabetes, CNS Disorder, CVD, Respiratory Disorder, MSD, GI, Drug addiction), by Product Type (Software, Hardware), by End User (B2B, B2C), and by Region - Forecast to 2026